Connection

Co-Authors

This is a "connection" page, showing publications co-authored by CONSTANCE ALBARRACIN and ERIKA RESETKOVA.
Connection Strength

1.468
  1. Discordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancers. Breast Cancer Res Treat. 2024 Jan; 203(1):73-83.
    View in: PubMed
    Score: 0.230
  2. Invasive paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast. Am J Surg Pathol. 2012 Sep; 36(9):1353-8.
    View in: PubMed
    Score: 0.107
  3. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast. Breast J. 2010 Nov-Dec; 16(6):573-80.
    View in: PubMed
    Score: 0.094
  4. Is it too soon to start reporting HER2 genetic heterogeneity? Arch Pathol Lab Med. 2010 Feb; 134(2):162-3; author reply 163.
    View in: PubMed
    Score: 0.089
  5. Loss of annexin A1 expression in breast cancer progression. Appl Immunohistochem Mol Morphol. 2008 Dec; 16(6):530-4.
    View in: PubMed
    Score: 0.083
  6. Management of radial sclerosing lesions of the breast diagnosed using percutaneous vacuum-assisted core needle biopsy: recommendations for excision based on seven years' of experience at a single institution. Breast Cancer Res Treat. 2011 Jun; 127(2):335-43.
    View in: PubMed
    Score: 0.080
  7. Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases. Mod Pathol. 2008 Feb; 21(2):201-7.
    View in: PubMed
    Score: 0.077
  8. Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma. Appl Immunohistochem Mol Morphol. 2007 Dec; 15(4):451-5.
    View in: PubMed
    Score: 0.077
  9. Giant cell tumor of soft tissue arising in breast. Ann Diagn Pathol. 2007 Oct; 11(5):345-9.
    View in: PubMed
    Score: 0.075
  10. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer. 2007 Feb 15; 109(4):658-67.
    View in: PubMed
    Score: 0.073
  11. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer. 2006 Oct 15; 107(8):1760-8.
    View in: PubMed
    Score: 0.071
  12. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res. 2006 Aug 01; 12(15):4598-604.
    View in: PubMed
    Score: 0.070
  13. A large, fungating breast mass. Secretory carcinoma with apocrine differentiation. Arch Pathol Lab Med. 2006 Apr; 130(4):e50-2.
    View in: PubMed
    Score: 0.069
  14. Collagenous spherulosis of breast: morphologic study of 59 cases and review of the literature. Am J Surg Pathol. 2006 Jan; 30(1):20-7.
    View in: PubMed
    Score: 0.067
  15. Metastatic nonhematopoietic neoplasms to the breast: a study of 238 cases. Hum Pathol. 2022 07; 125:59-67.
    View in: PubMed
    Score: 0.052
  16. TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma. Hum Pathol. 2022 07; 125:97-107.
    View in: PubMed
    Score: 0.052
  17. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol. 2022 03; 121:73-80.
    View in: PubMed
    Score: 0.051
  18. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology. 2011 Jul; 59(1):106-15.
    View in: PubMed
    Score: 0.025
  19. Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol. 2011 Aug; 42(8):1169-77.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.